CN112843131A - Oral liquid for treating mammary gland hyperplasia mastitis - Google Patents
Oral liquid for treating mammary gland hyperplasia mastitis Download PDFInfo
- Publication number
- CN112843131A CN112843131A CN202110180564.8A CN202110180564A CN112843131A CN 112843131 A CN112843131 A CN 112843131A CN 202110180564 A CN202110180564 A CN 202110180564A CN 112843131 A CN112843131 A CN 112843131A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- liquorice
- mammary gland
- mastitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an oral liquid for treating mammary gland hyperplasia mastitis, which comprises the following raw materials in parts by weight: 15-19 parts of pangolin, 10-18 parts of chaulmoogratree seed, 15-19 parts of semen momordicae, 15-19 parts of rheum officinale, 15-19 parts of liquorice and 500 parts of high-alcohol wine 400-. The invention has the effects of promoting blood circulation, eliminating mass, stimulating the menstrual flow, promoting lactation, reducing swelling, expelling pus, preventing galactostasis and the like by matching the pangolin, chaulmoogra, the rhubarb and the liquorice, helps balance hormone content in a female body by using the glycyrrhizin contained in the liquorice while regulating the pungency of other medicines, can effectively block tumor growth induced by carcinogens by using the hypochlorous acid contained in the liquorice, improves the treatment effect, avoids adverse effects of internal medicines on body functions, is convenient to store because Chinese herbal medicine properties and organic matters are easy to separate out through high-alcohol wine, and has the advantages of simple manufacturing process, cost saving and convenient use.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to an oral liquid for treating mammary gland hyperplasia mastitis.
Background
The breast is an important mark of female sexual characteristics, and the gland of the breast is similar to sweat gland, and the breast is regressed from the embryonic stage to the old stage and changes in the embryonic stage, the childhood stage, the adolescence stage, the pregnancy stage, the lactation stage and the old stage. Changes in the mammary gland are endocrine affected at each stage, i.e. as the ovary changes cyclically, the corresponding changes occur. Endocrine disturbance is the main cause of mastopathy, and the breast is affected due to infection and trauma caused by the uncoordinated secretion of estrogen. In addition, when nerves are under anxiety, tension or easy strong stimulation, and the intake of polyunsaturated fatty acids in high-fat diet is increased, the probability of breast lesions is also increased, and common mastopathies include hyperplasia of mammary glands, mastitis, fibroadenoma of breast, galactocele, breast cancer and the like.
Mastitis is an acute suppurative disease of mammary gland, generally caused by staphylococcus aureus infection, and is commonly seen in lactation period of primiparous women. The milk deposition is most likely to occur under the conditions of improper nursing method, unsmooth milk outflow, blocked mammary duct and the like, so that the bacteria reproduction is caused; or in the case of a ruptured nipple, a malformed nipple, or a traumatic injury to the nipple, bacteria may spread from the nipple back into the breast to the mammary gland, causing infection, causing mastitis,
hyperplasia of mammary glands refers to hyperplasia of mammary epithelium and fibrous tissue, degenerative changes of mammary tissue ducts and mammary lobules in structure and growth of progressive connective tissue, and the pathogenesis is mainly due to endocrine hormone imbalance. Hyperplasia of mammary glands is the most common breast disease in women, and the incidence rate accounts for the first place of breast diseases. The incidence of the disease has been increasing year by year in recent years, and the age has been getting lower. About 70-80% of women have different degrees of hyperplasia of mammary glands according to the survey, and the number of women is more than 25-45 years old.
At present, a plurality of methods for treating hyperplasia of mammary glands and mastitis exist, common western medicines such as oral hormone medicines or operation treatment are adopted, the oral hormone medicines can relieve some symptoms, but the aim of thorough cure is difficult to achieve, the side effect of the medicines is great, and the canceration of the medicines is possibly increased. The traditional Chinese medicine treatment mainly comprises soothing the liver, relieving depression, eliminating stagnation and removing blood stasis, and clinically common medicines comprise Xiaoyao pills, nodules of breast, Xiaojin capsules, which have different degrees of curative effects, but have long symptom improving time, low general cure rate and can not effectively inhibit tumor growth, so that the oral liquid for treating the mammary gland hyperplasia mastitis is provided to solve the problems.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides an oral liquid for treating hyperplasia of mammary glands and mastitis.
In order to achieve the purpose, the invention adopts the following technical scheme:
an oral liquid for treating mammary gland hyperplasia mastitis comprises the following raw materials in parts by weight: 15-19 parts of pangolin, 10-18 parts of chaulmoogratree seed, 15-19 parts of semen momordicae, 15-19 parts of rheum officinale, 15-19 parts of liquorice and 500 parts of high-alcohol wine 400-.
Preferably, the feed comprises the following raw materials in parts by weight: 16-18 parts of pangolin scales, 12-16 parts of chaulmoogratree seeds, 16-18 parts of momordica cochinchinensis seeds, 16-18 parts of rheum officinale, 16-18 parts of liquorice and 475 parts of Gaojiu 425 and wine.
Preferably, the feed comprises the following raw materials in parts by weight: 17 parts of pangolin, 14 parts of chaulmoogratree seed, 17 parts of semen momordicae, 17 parts of rhubarb, 17 parts of liquorice and 450 parts of high-alcohol wine.
Preferably, fresh unfused materials of pangolin scales, chaulmoogra seeds, momordica cochinchinensis seeds and rhubarb are adopted.
Preferably, the high-alcohol wine is white spirit with alcohol degree higher than 55 degrees and less than 65 degrees.
Preferably, the preparation method of the oral liquid for treating mammary gland hyperplasia mastitis comprises the following steps:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the liquor according to the parts by weight into a high-temperature resistant vessel with scale marks, soaking the pangolin scales, the chaulmoogratree seeds, the cochinchina momordica seeds, the rhubarb and the liquorice in the liquor according to the parts by weight for 19-23 hours, and sealing the vessel;
s3, the medicine soaked in the high-alcohol wine is ignited to burn until the residual amount of the high-alcohol wine is 160 and 200 g, and then the oral liquid is obtained.
Compared with the prior art, the invention has the beneficial effects that:
1. the invention has the effects of promoting blood circulation, eliminating mass, stimulating the menstrual flow, promoting lactation, reducing swelling, expelling pus, preventing milk obstruction and the like by matching the pangolin scales, the chaulmoogra seed, the rhubarb and the liquorice, and the liquorice is used for regulating the pungency of other medicines, and meanwhile, the glycyrrhizin contained in the liquorice is used for balancing the hormone content in a female body, the hypochlorous acid contained in the liquorice can be used for effectively blocking the tumor growth induced by carcinogens, the treatment effect is improved, and the adverse effect of oral medicines on the body function is avoided;
2. the Chinese herbal medicine is soaked in the high-quality white spirit with the alcohol content of 50-60 degrees, so that harmful microorganisms, parasites and worm eggs thereof in the medicinal materials can be killed to a great extent, the medicinal properties and organic matters of the Chinese herbal medicine can be easily separated out through the high-quality white spirit, the storage is convenient, the manufacturing process is simple, the cost is saved, and the use is convenient.
In conclusion, the invention has the effects of activating blood and eliminating mass, stimulating the menstrual flow and promoting lactation, reducing swelling and expelling pus, preventing lactation and the like by matching the pangolin scales, the chaulmoogra seeds, the rhubarb and the liquorice, helps balance hormone content in women by using the glycyrrhizin contained in the liquorice while regulating the toxicity of other medicines, also can effectively block tumor growth induced by carcinogens by using the hypochlorous acid contained in the liquorice, improves the treatment effect, avoids adverse effects of oral medicines on body functions, is convenient to store because Chinese herbal medicine properties and organic matters are easy to separate out by high alcohol, and has simple preparation process, cost saving and convenient use.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Example 1
An oral liquid for treating mammary gland hyperplasia mastitis comprises the following raw materials in parts by weight: 15 parts of pangolin, 10 parts of hydnocarpus, 15 parts of cochinchina momordica seed, 15 parts of rhubarb, 15 parts of liquorice and 400 parts of high-quality liquor, wherein the pangolin, the hydnocarpus, the cochinchina momordica seed and the rhubarb are all fresh materials which are not soaked, the high-quality liquor with the alcohol degree higher than 55 degrees and less than 65 degrees is white liquor, and the 55-65 degrees of high-quality white liquor can kill harmful microorganisms, parasites and insect eggs thereof in medicinal materials to a great extent in the process of soaking the Chinese herbal medicines, so that people can drink the oral liquid under the safe condition, and the preparation method of the oral liquid for treating mammary gland hyperplasia and mastitis comprises the following steps:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the high-alcohol wine into a high-temperature-resistant vessel with scale marks according to the parts by weight, soaking the pangolin scales, the chaulmoogra seeds, the momordica cochinchinensis seeds, the rheum officinale and the liquorice into the high-alcohol wine for 19 hours according to the parts by weight, and sealing the vessel;
s3, firing the medicine soaked in the high-alcohol wine until the weight of the medicine is 160 g of the high-alcohol wine, and obtaining the oral liquid.
Example 2
An oral liquid for treating mammary gland hyperplasia mastitis comprises the following raw materials in parts by weight: 16 parts of pangolin scales, 12 parts of hydnocarpus, 16 parts of semen momordicae, 16 parts of rheum officinale, 16 parts of liquorice and 425 parts of liquor with high alcohol content higher than 55 degrees and less than 65 degrees, wherein the fresh materials which are not soaked are adopted by the pangolin scales, the hydnocarpus, the semen momordicae and the rheum officinale, and the liquor with high alcohol content of 55-65 degrees can kill harmful microorganisms, parasites and worm eggs thereof in medicinal materials to a great extent in the process of soaking the Chinese herbal medicines, so that people can drink the liquor under safe conditions, and the preparation method of the oral liquid for treating mammary gland hyperplasia and mastitis comprises the following steps:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the high-alcohol wine into a high-temperature-resistant vessel with scale marks according to the parts by weight, soaking the pangolin scales, the chaulmoogra seeds, the momordica cochinchinensis seeds, the rheum officinale and the liquorice into the high-alcohol wine for 20 hours according to the parts by weight, and sealing the vessel;
s3, firing the medicine soaked in the high-alcohol wine until 170 g of the high-alcohol wine is left, and obtaining the oral liquid.
Example 3
An oral liquid for treating mammary gland hyperplasia mastitis comprises the following raw materials in parts by weight: 17 parts of pangolin, 14 parts of hydnocarpus macrophyllus, 17 parts of semen momordicae, 17 parts of rheum officinale, 17 parts of liquorice and 450 parts of high-quality liquor, wherein the pangolin, the hydnocarpus macrophyllus, the semen momordicae and the rheum officinale are all fresh materials which are not soaked, the high-quality liquor with the alcohol degree higher than 55 degrees and less than 65 degrees is white liquor, and the 55-65-degree high-quality white liquor can kill harmful microorganisms, parasites and insect eggs in medicinal materials to a great extent in the process of soaking the Chinese herbal medicines, so that people can drink the oral liquid under the safe condition, and the preparation method of the oral liquid for treating mammary gland hyperplasia and mastitis comprises the following steps:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the high-alcohol wine into a high-temperature-resistant vessel with scale marks according to the parts by weight, soaking the pangolin scales, the chaulmoogra seeds, the momordica cochinchinensis seeds, the rheum officinale and the liquorice into the high-alcohol wine for 21 hours according to the parts by weight, and sealing the vessel;
s3, firing the medicine soaked in the high-alcohol wine until 180 g of the high-alcohol wine is left, and obtaining the oral liquid.
Example 4
An oral liquid for treating mammary gland hyperplasia mastitis comprises the following raw materials in parts by weight: 18 parts of pangolin scales, 16 parts of hydnocarpus, 18 parts of semen momordicae, 18 parts of rheum officinale, 18 parts of liquorice and 475 parts of liquor with high alcohol content which is more than 55 degrees and less than 65 degrees, wherein the fresh materials which are not soaked are adopted by the pangolin scales, the hydnocarpus, the semen momordicae and the rheum officinale, and the liquor with high alcohol content of 55-65 degrees can kill harmful microorganisms, parasites and worm eggs thereof in medicinal materials to a great extent in the process of soaking Chinese herbal medicines, so that people can drink the liquor under safe conditions, and the preparation method of the oral liquid for treating mammary gland hyperplasia and mastitis comprises the following steps:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the liquor according to the parts by weight into a high-temperature resistant vessel with scale marks, soaking the pangolin scales, the chaulmoogratree seeds, the cochinchina momordica seeds, the rheum officinale and the liquorice in the liquor according to the parts by weight for 22 hours, and sealing the vessel;
s3, firing the medicine soaked in the high-alcohol wine until 190 g of the high-alcohol wine is left, and obtaining the oral liquid.
Example 5
An oral liquid for treating mammary gland hyperplasia mastitis comprises the following raw materials in parts by weight: 19 parts of pangolin scales, 18 parts of hydnocarpus macrophyllus, 19 parts of semen momordicae, 19 parts of rheum officinale, 19 parts of liquorice and 500 parts of high-quality liquor, wherein the pangolin scales, the hydnocarpus macrophyllus, the semen momordicae and the rheum officinale are all fresh materials which are not soaked, the high-quality liquor with the alcohol degree higher than 55 degrees and lower than 65 degrees is white liquor, and the 55-65 degrees of high-quality white liquor can kill harmful microorganisms, parasites and insect eggs in medicinal materials to a great extent in the process of soaking the Chinese herbal medicines, so that people can drink the oral liquid under the safe condition, and the preparation method of the oral liquid for treating mammary gland hyperplasia and mastitis comprises the following:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the high-alcohol wine into a high-temperature-resistant vessel with scale marks according to the parts by weight, soaking the pangolin scales, the chaulmoogra seeds, the momordica cochinchinensis seeds, the rheum officinale and the liquorice into the high-alcohol wine for 23 hours according to the parts by weight, and sealing the vessel;
s3, firing the medicine soaked in the high-alcohol wine until 200 g of the high-alcohol wine is left, and obtaining the oral liquid.
In the invention, when in preparation, the chaulmoogra, the momordica cochinchinensis and the rhubarb are pried and picked according to the weight ratio for standby, the spirit with high degree is taken according to the weight ratio and placed in a high-temperature resistant vessel with scale lines, the pangolin, the chaulmoogra, the momordica cochinchinensis, the rhubarb and the liquorice are taken according to the weight ratio and soaked in the spirit with high degree for 19 to 23 hours, the vessel is sealed, the medicine soaked in the spirit with high degree is burnt to the residual 160 grams of the spirit with high degree, thus obtaining the oral liquid, the spirit with high degree is ignited and burnt conveniently to reduce the alcoholic strength for convenient eating, the pangolin is used as an animal medicine, has strong effects of activating blood and eliminating mass, and can be used for treating traumatic injuries, joint swelling and pain, rib pain, hemiplegia, swelling and pus discharge, various lymphadenectasis, tumor masses and various cancers The invention also can be used for treating symptoms such as breast distending pain and hardening, and the like, wherein chaulmoogra seed, cochinchina momordica seed and rhubarb respectively have the efficacies of eliminating stagnation and reducing swelling, counteracting toxic substances and curing sore, attacking accumulation stagnation, clearing damp-heat, purging fire, cooling blood, removing blood stasis, detoxifying and the like, are used for treating symptoms such as pyocutaneous disease pyogenic infections, acute mastitis, scrofula, anal fistula, tinea pedis, leprosy, scabies and the like, glycyrrhizic acid contained in liquorice is used for regulating the fulness and toxicity of the chaulmoogra seed, cochinchina momordica seed and rhubarb, and liquiritigenin contained in liquorice is used for balancing the hormone content in a female body, hypochlorous acid contained in the liquorice is used for effectively blocking carcinogens from inducing tumor growth, the components of the Chinese herbal medicines are all organic matters, the organic matters are easily dissolved in an alcohol solution, and the precipitation of the Chinese herbal medicines is easy to occur when the alcohol content is higher, therefore, the invention adopts high-quality white spirit with 50-60 ℃ to soak, and can, The invention has reasonable formula and simple preparation process, one medicine can be drunk for 3 to 5 days according to the specification and disease conditions, pregnant women are forbidden to take the medicine, and the medicine cannot be taken together with other medicines during the medicine drinking period.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (6)
1. An oral liquid for treating mammary gland hyperplasia mastitis is characterized in that: the feed comprises the following raw materials in parts by weight: 15-19 parts of pangolin, 10-18 parts of chaulmoogratree seed, 15-19 parts of semen momordicae, 15-19 parts of rheum officinale, 15-19 parts of liquorice and 500 parts of high-alcohol wine 400-.
2. An oral liquid for treating mammary gland hyperplasia mastitis according to claim 1, wherein the oral liquid comprises: the feed comprises the following raw materials in parts by weight: 16-18 parts of pangolin scales, 12-16 parts of chaulmoogratree seeds, 16-18 parts of momordica cochinchinensis seeds, 16-18 parts of rheum officinale, 16-18 parts of liquorice and 475 parts of Gaojiu 425 and wine.
3. An oral liquid for treating mammary gland hyperplasia mastitis according to claim 1, wherein the oral liquid comprises: the feed comprises the following raw materials in parts by weight: 17 parts of pangolin, 14 parts of chaulmoogratree seed, 17 parts of semen momordicae, 17 parts of rhubarb, 17 parts of liquorice and 450 parts of high-alcohol wine.
4. An oral liquid for treating mammary gland hyperplasia mastitis according to claim 1, wherein the oral liquid comprises: the pangolin scales, the chaulmoogra seeds, the cochinchina momordica seeds and the rhubarb are all fresh materials which are not soaked.
5. An oral liquid for treating mammary gland hyperplasia mastitis according to claim 1, wherein the oral liquid comprises: the high-alcohol wine is white spirit with alcohol degree higher than 55 degrees and less than 65 degrees.
6. An oral liquid for treating mammary gland hyperplasia mastitis according to claim 1, wherein the oral liquid comprises: a preparation method of an oral liquid for treating mammary gland hyperplasia mastitis comprises the following steps:
s1, prying the chaulmoogra, the cochinchina momordica seed and the rhubarb according to the weight ratio, and picking for later use;
s2, placing the liquor according to the parts by weight into a high-temperature resistant vessel with scale marks, soaking the pangolin scales, the chaulmoogratree seeds, the cochinchina momordica seeds, the rhubarb and the liquorice in the liquor according to the parts by weight for 19-23 hours, and sealing the vessel;
s3, the medicine soaked in the high-alcohol wine is ignited to burn until the residual amount of the high-alcohol wine is 160 and 200 g, and then the oral liquid is obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110180564.8A CN112843131A (en) | 2021-02-09 | 2021-02-09 | Oral liquid for treating mammary gland hyperplasia mastitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110180564.8A CN112843131A (en) | 2021-02-09 | 2021-02-09 | Oral liquid for treating mammary gland hyperplasia mastitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112843131A true CN112843131A (en) | 2021-05-28 |
Family
ID=75988089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110180564.8A Pending CN112843131A (en) | 2021-02-09 | 2021-02-09 | Oral liquid for treating mammary gland hyperplasia mastitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112843131A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168278A (en) * | 1996-06-18 | 1997-12-24 | 上海地康营养保健食品开发有限公司 | Antineoplastic Chinese medicine prepn and its prepn process |
| CN1546090A (en) * | 2003-12-10 | 2004-11-17 | �Ϻ��ٿ�ҩҵ����˾ | Anticancer Chinese traditional medicine preparation and preparation process and application thereof |
| CN102266466A (en) * | 2011-07-22 | 2011-12-07 | 潘健 | Chinese medicinal patch for treating hyperplasia of mammary glands |
| CN102380083A (en) * | 2011-11-15 | 2012-03-21 | 梁淑花 | External plaster for treating mammary gland hyperplasia and lactation mastitis |
| CN102552432A (en) * | 2012-03-17 | 2012-07-11 | 张磊磊 | External Chinese medicinal herb for treating mastitis |
| CN107693658A (en) * | 2017-11-09 | 2018-02-16 | 刘燚 | A kind of traditional Chinese powder medicine and application method for treating the proliferation of mammary gland |
-
2021
- 2021-02-09 CN CN202110180564.8A patent/CN112843131A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168278A (en) * | 1996-06-18 | 1997-12-24 | 上海地康营养保健食品开发有限公司 | Antineoplastic Chinese medicine prepn and its prepn process |
| CN1546090A (en) * | 2003-12-10 | 2004-11-17 | �Ϻ��ٿ�ҩҵ����˾ | Anticancer Chinese traditional medicine preparation and preparation process and application thereof |
| CN102266466A (en) * | 2011-07-22 | 2011-12-07 | 潘健 | Chinese medicinal patch for treating hyperplasia of mammary glands |
| CN102380083A (en) * | 2011-11-15 | 2012-03-21 | 梁淑花 | External plaster for treating mammary gland hyperplasia and lactation mastitis |
| CN102552432A (en) * | 2012-03-17 | 2012-07-11 | 张磊磊 | External Chinese medicinal herb for treating mastitis |
| CN107693658A (en) * | 2017-11-09 | 2018-02-16 | 刘燚 | A kind of traditional Chinese powder medicine and application method for treating the proliferation of mammary gland |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103877229B (en) | A kind of compound Chinese medicine extract and application thereof preventing and treating an avian colibacillosis | |
| CN102696910B (en) | Feed composition and traditional Chinese medicine for preventing and treating avian infectious laryngotracheitis | |
| CN103735965A (en) | Traditional Chinese medicinal prescription for preventing and treating trichomonad of pigeon, as well as preparation method and application thereof | |
| CN105709081B (en) | Pharmaceutical composition for treating infectious rhinitis of chicken, application and feed thereof | |
| CN111632089A (en) | Traditional Chinese medicine composition for treating cow mastitis and preparation method thereof | |
| AU2011101378A4 (en) | Traditional Chinese medicine perfusate for the treatment of dairy cow mastitis and a preparation method thereof | |
| CN109224024B (en) | Pharmaceutical composition for preventing and treating bacterial mixed infection of freshwater fish and application method thereof | |
| CN112843131A (en) | Oral liquid for treating mammary gland hyperplasia mastitis | |
| CN104523897B (en) | A kind of enema medicament composition for treating piglet epidemic diarrhea | |
| CN106267193A (en) | A kind of for infusion of medicine agent treating bovine mastitis and its preparation method and application | |
| CN105233144A (en) | Traditional Chinese medicine preparation for treating dermatomycoses of animals and preparation method of traditional Chinese medicine preparation | |
| CN104886352A (en) | Special healthcare dog food for bitches and preparation method of special healthcare dog food | |
| CN107812166A (en) | A kind of feed addictive for preventing fish acute gastroenteritis and preparation method thereof | |
| CN111990533A (en) | Fermented eucommia ulmoides leaf extract and application thereof in preparation of chicken feed | |
| CN111494509A (en) | A Chinese medicinal injection for treating mastitis of milk cow, and its preparation method | |
| CN112043730A (en) | Traditional Chinese medicine biological preparation for preventing and treating animal epidemic diseases | |
| CN110507736A (en) | It is a kind of for treating the traditional Chinese medicine infusion solution and preparation method thereof of dam endometritis | |
| CN1268355C (en) | Traditional Chinese medicine for treating cow endo metritis | |
| CN103041011B (en) | Oral drug for treating gosling candidiasis | |
| CN101314026B (en) | Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof | |
| CN105688171B (en) | Feed additive for chicks and preparation method thereof | |
| CN113082140B (en) | Traditional Chinese medicine compound for treating acute mastitis of dairy cows and preparation method thereof | |
| CN108578602B (en) | Traditional Chinese medicine composition for treating leukorrheal diseases and preparation method thereof | |
| CN106692483A (en) | Preparation capable of preventing and treating ascaris suum and preparation method | |
| CN108420861B (en) | Traditional Chinese medicine composition for preventing and treating poultry group I adenovirus and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210528 |